Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications. (Q38191484)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24573960%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

review article

1 reference

title

Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24573960%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

0 references

Adelino F Leite-Moreira

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24573960%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24573960%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Manuel J Ferreira-Pinto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24573960%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24573960%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Bernardo Sousa-Pinto

1 reference

30 August 2017

Manuel J Ferreira-Pinto

1 reference

30 August 2017

Mário Santos

1 reference

30 August 2017

publication date

1 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24573960%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

published in

Heart Failure Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24573960%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24573960%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24573960%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

759-779

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24573960%20AND%20SRC:MED&resulttype=core&format=json

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

The human sympathetic nervous system: its relevance in hypertension and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

The role of the renin-angiotensin-aldosterone system in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Proinflammatory cytokines in heart failure: double-edged swords

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Molecular forms of natriuretic peptides in heart failure and their implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

The origin of sympathetic outflow in heart failure: the roles of angiotensin II and nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Sympathetic activation in congestive heart failure: evidence, consequences and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Adrenergic nervous system in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Impaired β-adrenergic receptor signalling in post-resuscitation myocardial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Modifications to central neural circuitry during heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

21 January 2018

Neurohumoral stimulation

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Brain angiotensin-converting enzyme activity and autonomic regulation in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Pharmacological treatment for heart failure: a view from the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Novel therapeutic targets for the treatment of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Biventricular pacing: current trends and future strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Renal denervation: current implications and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Rationale and study design of the increase of vagal tone in heart failure study: INOVATE-HF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

A "love triangle" elicited by electrochemistry: complex interactions among cardiac sympathetic afferent, chemo-, and baroreflexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

The sympathetic control of blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Cardiac sympathetic afferent stimulation augments the arterial chemoreceptor reflex in anesthetized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Interaction between cardiac sympathetic afferent reflex and chemoreflex is mediated by the NTS AT1 receptors in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Inhibition of cardiac sympathetic afferent reflex and sympathetic activity by baroreceptor and vagal afferent inputs in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Cardiac sympathetic afferent reflexes in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Gene transfer of neuronal nitric oxide synthase to carotid body reverses enhanced chemoreceptor function in heart failure rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

nNOS gene transfer to RVLM improves baroreflex function in rats with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Aldosterone reduces baroreceptor discharge in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

A role for the paraventricular nucleus of the hypothalamus in the autonomic control of heart and kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

AT1 receptors in the nucleus tractus solitarii mediate the interaction between the baroreflex and the cardiac sympathetic afferent reflex in anesthetized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Augmented input from cardiac sympathetic afferents inhibits baroreflex in rats with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

The projection and synaptic organisation of NTS afferent connections with presympathetic neurons, GABA and nNOS neurons in the paraventricular nucleus of the hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: the altered inhibitory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Hypothalamic paraventricular nucleus and cardiovascular regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

An immunohistochemical investigation of the relationship between neuronal nitric oxide synthase, GABA and presympathetic paraventricular neurons in the hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Neurons in the hypothalamic paraventricular nucleus send collaterals to the spinal cord and to the rostral ventrolateral medulla in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Identification of branching paraventricular neurons of the hypothalamus that project to the rostroventrolateral medulla and spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Paraventricular hypothalamic nucleus: axonal projections to the brainstem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Fos expression in spinally projecting neurons after hypotension in the conscious rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Medullary and supramedullary mechanisms regulating sympathetic vasomotor tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

The baroreflex and beyond: control of sympathetic vasomotor tone by GABAergic neurons in the ventrolateral medulla

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

The paraventricular nucleus: an important component of the central neurocircuitry regulating sympathetic nerve outflow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Interaction between glutamate and GABA systems in the integration of sympathetic outflow by the paraventricular nucleus of the hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Gene Transfer of Neuronal Nitric Oxide Synthase to the Paraventricular Nucleus Reduces the Enhanced Glutamatergic Tone in Rats With Chronic Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Nitric oxide inhibits the expression of AT1 receptors in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Heart failure and the brain: new perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Regulation of transcription factors by nitric oxide in neurons and in neural-derived tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Nitric oxide and homeostatic control: an intercellular signalling molecule contributing to autonomic and neuroendocrine integration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Alteration of NMDA NR1 receptors within the paraventricular nucleus of hypothalamus in rats with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Efferent neural projections of angiotensin receptor (AT1) expressing neurones in the hypothalamic paraventricular nucleus of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Angiotensin depolarizes parvocellular neurons in paraventricular nucleus through modulation of putative nonselective cationic and potassium conductances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Mitogen-activated protein kinases mediate upregulation of hypothalamic angiotensin II type 1 receptors in heart failure rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Decreased nNOS in the PVN leads to increased sympathoexcitation in chronic heart failure: role for CAPON and Ang II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Plasticity of pre- and postsynaptic GABAB receptor function in the paraventricular nucleus in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Dual GABAA receptor-mediated inhibition in rat presympathetic paraventricular nucleus neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Median preoptic nucleus and subfornical organ drive renal sympathetic nerve activity via a glutamatergic mechanism within the paraventricular nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Paraventricular nucleus, stress response, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

ANG II-induced excitation of paraventricular nucleus magnocellular neurons: a role for glutamate interneurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Angiotensin II type 2 receptors have a major somatodendritic distribution in vasopressin-containing neurons in the mouse hypothalamic paraventricular nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

c-Src in paraventricular nucleus modulates sympathetic activity and cardiac sympathetic afferent reflex in renovascular hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Signaling mechanisms of angiotensin II-induced attenuation of GABAergic input to hypothalamic presympathetic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Endogenous hydrogen peroxide in paraventricular nucleus mediating cardiac sympathetic afferent reflex and regulating sympathetic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Angiotensin II upregulates hypothalamic AT1 receptor expression in rats via the mitogen-activated protein kinase pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

S-nitrosylation of cysteine 289 of the AT1 receptor decreases its binding affinity for angiotensin II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Angiotensin II-mediated posttranslational modification of nNOS in the PVN of rats with CHF: role for PIN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Increased stress-evoked nitric oxide signalling in the Flinders sensitive line (FSL) rat: a genetic animal model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Increased expression in dorsolateral prefrontal cortex of CAPON in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

AT2 receptor signaling and sympathetic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Angiotensin-converting enzyme 2 overexpression improves central nitric oxide-mediated sympathetic outflow in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Does aldosterone upregulate the brain renin-angiotensin system in rats with heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Effects of ACTH, dexamethasone, and adrenalectomy on 11beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) gene expression in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Regulation of hypothalamic renin-angiotensin system and oxidative stress by aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Aldosterone-induced brain MAPK signaling and sympathetic excitation are angiotensin II type-1 receptor dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

21 January 2018

Aldosterone in the brain

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Cytokines as new treatment targets in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Cross-talk between cytokines and renin-angiotensin in hypothalamic paraventricular nucleus in heart failure: role of nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Central gene transfer of interleukin-10 reduces hypothalamic inflammation and evidence of heart failure in rats after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Brain cytokines as neuromodulators in cardiovascular control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Novel effect of mineralocorticoid receptor antagonism to reduce proinflammatory cytokines and hypothalamic activation in rats with ischemia-induced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Role of circumventricular organs in pro-inflammatory cytokine-induced activation of the hypothalamic-pituitary-adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Subdiaphragmatic vagotomy inhibits intra-abdominal interleukin-1 beta stimulation of adrenocorticotropin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Subfornical organ mediates sympathetic and hemodynamic responses to blood-borne proinflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

EP₃ receptors mediate PGE₂-induced hypothalamic paraventricular nucleus excitation and sympathetic activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Brain perivascular macrophages and the sympathetic response to inflammation in rats after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Regulation of the hypothalamo-pituitary-adrenal axis by cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Interaction between AT1 receptor and NF-κB in hypothalamic paraventricular nucleus contributes to oxidative stress and sympathoexcitation by modulating neurotransmitters in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Cytokine mediation of experimental heart failure-induced anhedonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Cognitive/affective and somatic/affective symptom dimensions of depression are associated with current and future inflammation in heart failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Angiotensin II AT1 receptor blockade ameliorates brain inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Brain and mood changes over 2 years in healthy controls and adults with heart failure and ischaemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Cognitive and brain changes associated with ischaemic heart disease and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Visual assessment of brain magnetic resonance imaging detects injury to cognitive regulatory sites in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

A postmortem assessment of mammillary body volume, neuronal number and densities, and fornix volume in subjects with mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Neurochemistry of the paraventricular nucleus of the hypothalamus: implications for cardiovascular regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Comparison of vasopressin and oxytocin expressions in the hypothalamo-neurohypophysial system of patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

A spinal vasopressinergic mechanism mediates hyperosmolality-induced sympathoexcitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Terminals of paraventricular spinal neurones are closely associated with adrenal medullary sympathetic preganglionic neurones: immunocytochemical evidence for vasopressin as a possible neurotransmitter in this pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

The distribution of oxytocin- and neurophysin-stained fibers in the spinal cord of the rat and monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Cardiovascular responses to chemical stimulation of the hypothalamic arcuate nucleus in the rat: role of the hypothalamic paraventricular nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Clinical and neurohormonal correlates and prognostic value of serum prolactin levels in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Decreased brain sigma-1 receptor contributes to the relationship between heart failure and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Angiotensin-converting enzyme is present in the subfornical organ and other circumventricular organs of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Inhibition of tissue angiotensin converting enzyme. Quantitation by autoradiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Angiotensin converting enzyme in rat brain visualized by quantitative in vitro autoradiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Central nervous system blockade by peripheral administration of AT1 receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Peripherally administered angiotensin II AT1 receptor antagonists are anti-stress compounds in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Central mineralocorticoid receptor blockade decreases plasma TNF-alpha after coronary artery ligation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Immunological mechanisms of pentoxifylline in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Post-ischemic treatment of pentoxifylline reduces cortical not striatal infarct volume in transient model of focal cerebral ischemia in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Therapeutic potential of tumour necrosis factor-alpha antagonists in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

CNS drug delivery systems: novel approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Oral treatment with the NADPH oxidase antagonist apocynin mitigates clinical and pathological features of parkinsonism in the MPTP marmoset model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

High dose ascorbic acid does not reverse central sympathetic overactivity in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Scavenging superoxide selectively in mouse forebrain is associated with improved cardiac function and survival following myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Peroxisome proliferator-activated receptor-γ regulates inflammation and renin-angiotensin system activity in the hypothalamic paraventricular nucleus and ameliorates peripheral manifestations of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Strong inhibition of replicative DNA synthesis in the developing rat cerebral cortex and glioma cells by roscovitine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Selective CDK inhibitor limits neuroinflammation and progressive neurodegeneration after brain trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Suppression of the clinical and cytokine response to endotoxin by RWJ-67657, a p38 mitogen-activated protein-kinase inhibitor, in healthy human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

The effect of selective serotonin re‐uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

The role of the selective serotonin re-uptake inhibitor sertraline in nondepressive patients with chronic ischemic heart failure: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Chronic fluoxetine reduces autonomic control of cardiac rhythms in rats with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Renal sympathetic denervation and systemic hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Unilateral renal denervation improves autonomic balance in conscious rabbits with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Covariate adjustment in heart failure randomized controlled clinical trials: a case analysis of the HF-ACTION trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

The effects of exercise training on sympathetic neural activation in advanced heart failure: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Central neural control of sympathetic nerve activity in heart failure following exercise training

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9427-X

Adrenergic pathways and left ventricular remodeling

21 January 2018

1 reference

12 December 2020

Evidence for an Intramedullary Prostaglandin-Dependent Mechanism in the Activation of Stress-Related Neuroendocrine Circuitry by Intravenous Interleukin-1

1 reference

12 December 2020

Angiotensin II enhances carotid body chemoreflex control of sympathetic outflow in chronic heart failure rabbits

1 reference

12 December 2020

Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study)

1 reference

12 December 2020

Cardiac vagal chemosensory afferents. Function in pathophysiological states.

1 reference

12 December 2020

Comment on ESH position paper: renal denervation--an interventional therapy of resistant hypertension

1 reference

12 December 2020

Telmisartan ameliorates glutamate-induced neurotoxicity: roles of AT(1) receptor blockade and PPARγ activation

1 reference

12 December 2020

A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons.

1 reference

12 December 2020

Depressive symptoms and inflammatory biomarkers in patients with heart failure

1 reference

12 December 2020

NMDA-mediated increase in renal sympathetic nerve discharge within the PVN: role of nitric oxide

1 reference

12 December 2020

Signalling pathway of nitric oxide in synaptic GABA release in the rat paraventricular nucleus

1 reference

12 December 2020

Expression of mineralocorticoid and glucocorticoid receptors in preautonomic neurons of the rat paraventricular nucleus

1 reference

12 December 2020

Treating inflammation by blocking interleukin-1 in humans

1 reference

12 December 2020

Do high doses of AT(1)-receptor blockers attenuate central sympathetic outflow in humans with chronic heart failure?

1 reference

12 December 2020

Depressive symptoms and inflammation among heart failure patients

1 reference

12 December 2020

Hypertension. Cardiac effects of renal denervation

1 reference

12 December 2020

Ventricular mechanoreflex and chemoreflex alterations in chronic heart failure

1 reference

12 December 2020

Depleting Serotonin Enhances Both Cardiovascular and Psychological Stress Reactivity in Recovered Patients With Anxiety Disorders

1 reference

12 December 2020

Noradrenergic regulation of parvocellular neurons in the rat hypothalamic paraventricular nucleus

1 reference

12 December 2020

ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension

1 reference

12 December 2020

Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure

1 reference

12 December 2020

Blunted nitric oxide-mediated inhibition of renal nerve discharge within PVN of rats with heart failure

1 reference

12 December 2020

Role of gamma-aminobutyric acid (GABA)A and GABAB receptors in paraventricular nucleus in control of sympathetic vasomotor tone in hypertension

1 reference

12 December 2020

Contribution of cardiopulmonary baroreceptors to the control of the kidney

1 reference

12 December 2020

Distribution of Fos-immunoreactivity in rat brain following a dipsogenic dose of captopril and effects of angiotensin receptor blockade

1 reference

12 December 2020

Blockade of angiotensin converting enzyme in circumventricular organs of the brain after oral lisinopril administration demonstrated by quantitative in vitro autoradiography

1 reference

12 December 2020

Peripheral chemoreflex activation contributes to sympathetic baroreflex impairment in chronic heart failure

1 reference

12 December 2020

Vasopressin receptor antagonists: from pivotal trials to current practice

1 reference

12 December 2020

Regulation of arterial pressure by the paraventricular nucleus in conscious rats: interactions among glutamate, GABA, and nitric oxide.

1 reference

12 December 2020

Renal effects of left atrial distension in dogs with chronic congestive heart failure

1 reference

12 December 2020

Angiotensin II regulates renin gene expression

1 reference

12 December 2020

Role of NO on vasopressin and oxytocin release and blood pressure responses during osmotic stimulation in rats

1 reference

12 December 2020

In patients with heart failure elevated soluble TNF-receptor 1 is associated with higher risk of depression

1 reference

12 December 2020

Inflammatory cytokines in paraventricular nucleus modulate sympathetic activity and cardiac sympathetic afferent reflex in rats.

1 reference

12 December 2020

Expression of ionotropic glutamate receptor subunit mRNAs in the hypothalamic paraventricular nucleus of the rat.

1 reference

12 December 2020

A clinical prediction rule to identify patients at heightened risk for early demise following cardiac resynchronization therapy

1 reference

12 December 2020

Effects of bilateral vagal cold block on vasopressin in conscious dogs

1 reference

12 December 2020

Neuropeptide Y modulation of sympathetic activity in myocardial infarction

1 reference

12 December 2020

Subfornical organ efferents to paraventricular nucleus utilize angiotensin as a neurotransmitter

1 reference

12 December 2020

Adrenocorticotropin release induced by intracerebroventricular injection of recombinant human interleukin-1 in rats: possible involvement of prostaglandin

1 reference

12 December 2020

In patients with stable heart failure, soluble TNF-receptor 2 is associated with increased risk for depressive symptoms

1 reference

12 December 2020

Control of sympathetic nerve activity by vagal mechanoreflexes is blunted in heart failure

1 reference

12 December 2020

The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat.

1 reference

12 December 2020